Investors are on the edge of their collective seats, hoping that Synovus
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Synovus with 13 of 17 analysts rating it hold. Analysts don't like Synovus as much as competitor First Horizon National overall. Nine out of 20 analysts rate First Horizon National a buy compared to two of 17 for Synovus. While analysts still rate the stock a hold, they are a little more optimistic about it compared to three months ago.
- Revenue Forecasts: On average, analysts predict $287.1 million in revenue this quarter. That would represent a decline of 4.8% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.01 per share. Estimates range from breaking even to a profit of $0.02.
What our community says:
CAPS All-Stars are solidly supporting the stock, with 84.3% giving it an "outperform" rating. The greater community agrees with the All-Stars, as 87.5% give it a rating of "outperform." Though still bullish, the CAPS rating of four out of five stars for Synovus is a bit more pessimistic than the community assessment.
Now, a look at how efficient management has been at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The company's net margins have been increasing year-over-year for the last four quarters. Net margins reflect what percentage of revenue becomes profit. Here are Synovus' reported margins for the last four quarters:
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.